Modular Medical (MODD) Cash from Investing Activities (2020 - 2026)
Modular Medical (MODD) posted Cash from Investing Activities of -$1.0 million for Q1 2026, up 17.76% on a QoQ basis from -$1.2 million in Q4 2025, and down 6.01% year-over-year from -$1.1 million in Q1 2025.
Modular Medical (MODD) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Modular Medical's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- Quarterly Cash from Investing Activities fell 6.01% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.9 million (down 57.72% YoY) and the FY2026 annual result came in at -$3.9 million, down 57.72% from the prior year.
- Cash from Investing Activities was -$1.0 million for Q1 2026 at Modular Medical, up from -$1.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$5000.0 in Q3 2022 and bottomed at -$1.2 million in Q4 2025.
- A 5-year average of -$576175.6 and a median of -$499000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 24888.28% — and 2024, when it surged 54.65%.
- Modular Medical's Cash from Investing Activities stood at -$492000.0 in 2022, then retreated by 1.42% to -$499000.0 in 2023, then dropped by 8.62% to -$542000.0 in 2024, then tumbled by 125.46% to -$1.2 million in 2025, then grew by 17.76% to -$1.0 million in 2026.
- Business Quant data shows MODD's Cash from Investing Activities at -$1.0 million in Q1 2026, -$1.2 million in Q4 2025, and -$771000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Modular Medical | 3.75 Mn | -3.19 Mn | - | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -1.22 Mn |
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | -771,000.00 |
| Sep 30, 2025 | -771,000.00 |
| Jun 30, 2025 | -934,000.00 |
| Jun 30, 2025 | -934,000.00 |
| Mar 31, 2025 | -948,000.00 |
| Mar 31, 2025 | -948,000.00 |
| Dec 31, 2024 | -542,000.00 |
| Dec 31, 2024 | -542,000.00 |
| Sep 30, 2024 | -161,000.00 |
| Sep 30, 2024 | -161,000.00 |
| Jun 30, 2024 | -842,000.00 |
| Jun 30, 2024 | -842,000.00 |
| Mar 31, 2024 | -483,000.00 |
| Mar 31, 2024 | -483,000.00 |
| Dec 31, 2023 | -499,000.00 |
| Dec 31, 2023 | -499,000.00 |